These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36225496)

  • 1. A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam.
    Rubnitz ZA; Kunkel VN; Baselski VS; Summers NA
    Cureus; 2022 Sep; 14(9):e28855. PubMed ID: 36225496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam Combinations with Avibactam, Relebactam, and Vaborbactam as Treatment for New Delhi Metallo-β-Lactamase-Producing Enterobacterales Infections-In Vitro Susceptibility Testing.
    Brauncajs M; Bielec F; Malinowska M; Pastuszak-Lewandoska D
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria.
    Emeraud C; Escaut L; Boucly A; Fortineau N; Bonnin RA; Naas T; Dortet L
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858212
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Cervino I; Gonzalez D; Nastro M; Vega J; Reyes AP; Buriano G; Vay C; Famiglietti A; Rodriguez CH
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34605763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases.
    Mauri C; Maraolo AE; Di Bella S; Luzzaro F; Principe L
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing
    Bhatnagar A; Boyd S; Sabour S; Bodnar J; Nazarian E; Peinovich N; Wagner C; Craft B; Snippes Vagnone P; Simpson J; Stone VN; Therrien M; Bateman A; Lower D; Huang JY; Gumbis S; Lonsway D; Lutgring JD; Karlsson M; Brown AC
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0048621. PubMed ID: 34060895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.
    Khan A; Erickson SG; Pettaway C; Arias CA; Miller WR; Bhatti MM
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0084621. PubMed ID: 34424044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of
    Perrotta F; Perrini MP
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33924769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of aztreonam in combination with ceftazidime-avibactam against serine- and metallo-β-lactamase-producing Pseudomonas aeruginosa.
    Lee M; Abbey T; Biagi M; Wenzler E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115227. PubMed ID: 33086177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi metallo-β-lactamases.
    Feng K; Jia N; Zhu P; Sy S; Liu Y; Dong D; Zhu S; Zhang J; Liu Y; Martins FS; Gong H; Lv Z; Yu M; Sy SKB; Zhu Y
    J Antimicrob Chemother; 2021 Oct; 76(11):2875-2883. PubMed ID: 34383928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed
    Gupta N; Boodman C; Prayag P; Manesh A; Kumar TP
    Expert Rev Anti Infect Ther; 2024 Apr; 22(4):203-209. PubMed ID: 38258529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019.
    Sader HS; Carvalhaes CG; Arends SJR; Castanheira M; Mendes RE
    J Antimicrob Chemother; 2021 Feb; 76(3):659-666. PubMed ID: 33276387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of Antibiotic Activity of Aztreonam against Metallo-β-Lactamase-Producing Multidrug-Resistant
    Lee S; Lee T; Kim MK; Ahn JH; Jeong S; Park KH; Chong Y
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing
    Merad Y; Conrad A; Brosset S; Schmidt A; Hanriat C; Lustig S; Laurent F; Kolenda C; Roussel-Gaillard T; Batailler C; Ferry T;
    Front Med (Lausanne); 2023; 10():1224922. PubMed ID: 37601796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
    Piérard D; Stone GG
    BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing
    Falcone M; Tiseo G; Antonelli A; Giordano C; Di Pilato V; Bertolucci P; Parisio EM; Leonildi A; Aiezza N; Baccani I; Tagliaferri E; Righi L; Forni S; Sani S; Mechi MT; Pieralli F; Barnini S; Rossolini GM; Menichetti F
    Open Forum Infect Dis; 2020 Feb; 7(2):ofaa011. PubMed ID: 32042848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aztreonam, Ceftazidime/Avibactam, and Colistin Combination for the Management of Carbapenemase-Producing
    Shah PJ; Tran T; Emelogu F; Tariq F
    J Pharm Pract; 2021 Aug; 34(4):653-657. PubMed ID: 31698984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects.
    Zakhour J; El Ayoubi LW; Kanj SS
    Expert Rev Anti Infect Ther; 2024 Apr; 22(4):189-201. PubMed ID: 38275276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.